The Cost of Concealing Wealth When Playing Poor Backfires 401k Millionaire Count Dips as Workers Boost Savings to Record Levels Fidelity Q1 Data General Motors Unveils AllElectric Cadillac Vistiq With 300Mile Range Expanding Luxury EV Lineup Musk vs Altman Court Throws Out OpenAI Lawsuit as LongRunning Feud Ends Indias Fertilizer Subsidy May Surpass 3 Lakh Crore Amid West Asia Crisis Walmart CFO Notes Shoppers Filling Less Than 10 Gallons of Gas Citing Consumer Stress Amid Rising Fuel Costs AVB Q1 2026 Earnings Massive EPS Beat Drives Stock Higher Gran Tierra Energy Inc Q4 2025 Earnings Net Loss Reported as Oil Producer Navigates Lower Prices SPCE Q1 2026 Earnings Narrower Than Expected Loss as Company Reshapes Space Tourism Strategy Biodesix Inc BDSX Q1 2026 Earnings Strong EPS Beat Overshadowed by Negative Stock Reaction Wheeler Real Estate Investment Trust Inc Series D Cumulative Preferred Stock WHLRD Q2 2024 Earnings Preferred EPS Reported at 365 Stock Unchanged Sohucom SOHU Gains 214 as Shares Approach Key Resistance Tevogen Bio Holdings Warrant TVGNW Edges Higher in Thin Trading Inotiv Inc NOTV Continues Decline Testing Support Near 026 CytoMed Therapeutics GDTC Drops 738 Key Support Levels in Focus Amid Selling Pressure SilverBox Corp V SBXE Holds Steady at 998 as SPAC Trading Remains Muted Trainline Raises FullYear Guidance Again Citing Strong Demand TBPH Q1 2026 Earnings Narrower Loss Buoys Investor Sentiment Despite Zero Revenue Antero Midstream AM Gains 165 as Energy Infrastructure Demand Strengthens Bar Harbor Bankshares Inc Q1 2026 Earnings Missed EPS Estimates Amid Cautious Start to the Year FTFT Q2 2024 Earnings Net Loss of 009 Per Share as Company Pivots IPSC Q1 2026 Earnings EPS Beats Estimates Stock Declines Slightly as Pipeline Advances AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline MYE Q1 2026 Earnings Strong Earnings Beat as Profitability Surges Past Estimates AGIG Q3 2012 Earnings EPS Misses by Wide Margin Stock Rises Despite No Revenue Reported MDCX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Posts WiderthanExpected Loss